SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-23-010757
Filing Date
2023-03-30
Accepted
2023-03-30 08:01:58
Documents
85
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 10-K apvo-20221231.htm   iXBRL 10-K 3300942
2 EX-21.1 apvo-ex21_1.htm EX-21 10786
3 EX-23.1 apvo-ex23_1.htm EX-23 8701
4 EX-31.1 apvo-ex31_1.htm EX-31 20430
5 EX-31.2 apvo-ex31_2.htm EX-31 20422
6 EX-32.1 apvo-ex32_1.htm EX-32 13103
7 EX-32.2 apvo-ex32_2.htm EX-32 13344
8 GRAPHIC img133665602_0.jpg GRAPHIC 109015
9 GRAPHIC img133665602_1.jpg GRAPHIC 76219
10 GRAPHIC img133665602_2.jpg GRAPHIC 73113
11 GRAPHIC img133665602_3.jpg GRAPHIC 66136
  Complete submission text file 0000950170-23-010757.txt   11605420

Data Files

Seq Description Document Type Size
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT apvo-20221231_def.xml EX-101.DEF 245366
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT apvo-20221231_pre.xml EX-101.PRE 423042
14 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT apvo-20221231.xsd EX-101.SCH 72826
15 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT apvo-20221231_cal.xml EX-101.CAL 58622
16 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT apvo-20221231_lab.xml EX-101.LAB 570520
79 EXTRACTED XBRL INSTANCE DOCUMENT apvo-20221231_htm.xml XML 1741911
Mailing Address 2401 4TH AVE. SUITE 1050 SEATTLE WA 98121
Business Address 2401 4TH AVE. SUITE 1050 SEATTLE WA 98121 206-838-0500
Aptevo Therapeutics Inc. (Filer) CIK: 0001671584 (see all company filings)

IRS No.: 811567056 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-37746 | Film No.: 23777198
SIC: 2834 Pharmaceutical Preparations